Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 5.2B | 4.7B | 4.4B | 4.2B |
Cost of revenue | 2.6B | 2.4B | 2.3B | 2.2B |
Gross profit | 2.6B | 2.3B | 2.1B | 2.0B |
Operating expense | ||||
Research & development | 580.2M | 525.9M | 494.9M | 495.4M |
Selling general and admin | 268.4M | 226.0M | 244.2M | 243.1M |
Other operating expenses | — | — | — | — |
Operating income | 1.7B | 1.6B | 1.3B | 1.3B |
Non operating interest income | ||||
Income | 54.6M | 50.6M | 57.6M | 68.4M |
Expense | 42.8M | 45.2M | 45.3M | 44.9M |
Other income expense | 26.0M | -30.5M | 2.0M | 6.6M |
Pretax income | 1.8B | 1.5B | 1.3B | 1.3B |
Tax provision | 58.9M | 206.1M | 157.1M | 177.8M |
Net income | 1.7B | 1.3B | 1.2B | 1.1B |
Basic EPS | — | 1.0 | 0.9 | 0.9 |
Diluted EPS | — | 1.0 | 0.9 | 0.9 |
Basic average shares | — | 1.3B | 1.3B | 1.3B |
Diluted average shares | — | 1.3B | 1.3B | 1.3B |
EBITDA | 1.9B | 1.7B | 1.5B | 1.4B |
Net income from continuing op. | 1.7B | 1.3B | 1.2B | 1.1B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |